IPO lineup for 2020: Opportunities Await

If you have missed a few good investment opportunities in 2019, don’t lose heart.

There are few good opportunities coming your way in 2020.

The current year saw a mixed response from investors in the primary markets.

Few good counters were lapped up by investors while some failed to impress on their debut.

The IPO of Ujjivan Small Finance Bank Ltd. was oversubscribed 166 times, the most for this year. Few others such as IRCTC, IndiaMart InterMesh, Affle India, Polycab India, Neogem Chemical, received good response and have provided good returns through the blockbuster listing.

The 14 mainboard IPOs this year have risen by an average of more than 50% since listing.

The outperformance of recent debutantes is notable given the sluggish performance of smaller Indian shares in general.

While the key benchmark indices have rallied to record levels piggybacking the gains in large-cap stocks, investors continue to wait in the wings for good buying opportunities.

Their wait will be over soon as few good new offerings are on the card for 2020.

There are 21 companies that have filed documents with market regulator Securities & Exchange Board of India for planned IPOs, looking to raise a total of about 300 billion rupees ($4.2 billion).

There are 16 more that could be launched in 2020 including five AMC businesses.

Here’s the list of 16 big IPOs that could be listed in 2020. Of which 11 have already received approval to tap the market as soon as next year.

The most awaited ones are SBI Card, UTI AMC, and Reliance Jio, Reliance Retail.

HDFC Bank subsidiary HDB Financial while two subsidiaries of HDFC, HDFC Ergo, and HDFC Credilia will hit the primary markets.

Equitas Small Finance Bank, Kotak Mahindra AMC, PNB MetLife, Axis Bank AMC, L&T AMC, Aditya Birla AMC, Exide Life Insurance, Computer Age Management Services, and Fincare Small Finance Bank are also some of the candidates expected to go public soon.

Disclaimer –
This document is meant for the recipient only for use as intended and not for circulation. This document should not be reproduced or copied or made available to others. The information contained herein is from the public domain or sources believed to be reliable. While reasonable care has been taken to ensure that information given is at the time believed to be fair and correct and opinions based thereupon are reasonable, due to the very nature of research it cannot be warranted or represented that it is accurate or complete and it should not be relied upon as such. Also above note is not a recommendation to Buy or SELL and is only a view based on facts and figures and we will be in no way responsible for any losses incurred by anyone who uses this information to either trade or invests securities mentioned herein.